Why Shares of Arena Pharmaceuticals, Inc. Skyrocketed Today
Good news in a Phase 1 trial has this small biotech up big. Is this a justified pop?
Why Arena Pharmaceuticals, Inc. Stock Slumped 17% in December
Arena Pharmaceuticals stock took a tumble in December after a rival receives good news in the EU. Find out whether this dip is a buying opportunity or a red flag to keep your distance.